Bayer PharmaOvjeren akaunt

@BayerPharma

The global pharmaceutical division of . Data Privacy / Imprint:

Berlin, Germany
Vrijeme pridruživanja: lipanj 2009.

Tweetovi

Blokirali ste korisnika/cu @BayerPharma

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @BayerPharma

  1. proslijedio/la je Tweet
    prije 22 sata

    may be over, but until we’ve developed the cures and treatments to take out the big C for good

    Poništi
  2. proslijedio/la je Tweet
    4. velj

    What a powerful, emotional speech by in the European Parliament in the . Let‘s just follow his recommendations.

    Poništi
  3. 4. velj

    The community is our inspiration to drive change. What is your inspiration to take action in the fight against cancer? Create your own pledge and share it with the world:

    Poništi
  4. 4. velj

    At , we are inspired every day by the support in the community around the world. This , learn more about their stories and how we are driving change in cancer care:

    Poništi
  5. 3. velj

    Tomorrow is . At , we are sharing our pledges to show how we are inspired to take action against . What is your pledge? Create one yourself here:

    Poništi
  6. 31. sij

    : New treatment for men with from receives positive opinion

    Poništi
  7. 30. sij

    : Bayer submits application to for treatment of newborns, infants, and children suffering from disease

    Poništi
  8. 30. sij

    neglected tropical diseases still threaten the lives of around 1.5 billion people worldwide? is proud to be part of and is committed to

    Poništi
  9. proslijedio/la je Tweet
    30. sij

    On the first , let us be clear: no one in the world should have to suffer from a neglected tropical disease in 2020. It’s time to finally so that everyone has the chance to live a healthy, productive, dignified life.

    Poništi
  10. 30. sij

    : provides update on Phase III results for therapy

    Poništi
  11. proslijedio/la je Tweet
    27. sij

    care in Europe: where are we in 2020? Read our latest report for a comprehensive overview of the progress achieved to date and new insights into the challenges that still need to be addressed

    Poništi
  12. 23. sij

    : submits application to for regulatory update on treatment

    Poništi
  13. 23. sij

    : receives approval in Japan for treatment:

    Poništi
  14. 21. sij

    : to highlight data from its expanding portfolio at

    Poništi
  15. 16. sij

    As comes to a close, we’re reflecting on an exciting week. Great to share information on our updated approach & looking forward to building the momentum of collaboration throughout 2020 and beyond to benefit patients around the world

    Poništi
  16. 16. sij

    ”At Leaps we also consider venture investment to be a marathon, not a sprint. We strongly believe in 4-6 years as an investment horizon to advance true breakthroughs rather than quick wins“, said Juergen Eckhardt, Head of

    Poništi
  17. proslijedio/la je Tweet
    15. sij

    We are inspired by people who push beyond what is considered possible – from the scientists dedicating their lives to potential breakthroughs, to individuals who defy their physical limits. To shift core paradigms in the life sciences, we must

    Poništi
  18. 15. sij

    : Read the story of research scientist Steven Ferrara from our partner on how joining forces through can make a change for . Full interview here:

    Poništi
  19. proslijedio/la je Tweet

    THANK YOU to all our guests -current and future partners- at ⁦'s Innovation and Partnering reception last night⁩ - we hope you enjoyed a night of inspiration focused on the patients we serve.

    Poništi
  20. 15. sij

    Live from : ‘s pharmaceutical division updating institutional investors on status of development portfolio and implementation of new strategy with focus on innovation, & , , , , at

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·